Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 17/20 | 0.51 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | CDK4 | P11802 | 1/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.47 |
| ▸ | CCND1 | P24385 | 1/20 | 0.47 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30352557 | 0.82 | PDE4B (0.50) | PDE4B | |
| SCHEMBL30352704 | 0.77 | PDE4B (0.67) | PDE4B | |
| SCHEMBL22991981 | 0.76 | PDE4B (0.49) | PDE4B | |
| SCHEMBL22991941 | 0.74 | PDE4B (0.65) | PDE4B | |
| SCHEMBL30352669 | 0.73 | PDE4B (0.74) | PDE4B | |
| SCHEMBL2512334 | 0.71 | LCK (0.86) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL13338339 | 0.71 | LCK (0.86) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL2512336 | 0.71 | LCK (0.86) | CCNB2CDK1CDK4CCNB1CCND1 | |
| SCHEMBL22991991 | 0.70 | PDE4B (0.78) | PDE4B | |
| SCHEMBL22991947 | 0.70 | PDE4B (0.77) | PDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3777979-A1 | ANTI-INFLAMMATORY COMPOUND AND PREPARATION AND USE THEREOF | Vivavision Biotech, Inc. (CN) | 2021-02-17 | — | — | EP | disclosed |